These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 7864898
1. Creation of a high cytotoxic active human tumor necrosis factor having the truncated and more basic amino terminus. Guo D, Shen B, Dong X, Qiu Q, Xu X. Biochem Biophys Res Commun; 1995 Feb 27; 207(3):927-32. PubMed ID: 7864898 [Abstract] [Full Text] [Related]
2. [Relationship between the structure--modified N- and C- termini and the biological activity of TNF alpha molecule]. Chang J, Li X, He X, Lu Q, Yu H, Cai W, Li C, Zhao S. Yi Chuan Xue Bao; 1995 Feb 27; 22(5):329-35. PubMed ID: 8679272 [Abstract] [Full Text] [Related]
3. Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity. Masegi T, Kato A, Kitai K, Fukuoka M, Ogawa H, Ichikawa Y, Nakamura S, Watanabe N, Niitsu Y. Jpn J Cancer Res; 1995 Jan 27; 86(1):72-80. PubMed ID: 7737913 [Abstract] [Full Text] [Related]
4. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. Zhang XM, Weber I, Chen MJ. J Biol Chem; 1992 Nov 25; 267(33):24069-75. PubMed ID: 1331108 [Abstract] [Full Text] [Related]
5. Hydrophobic cavity in C-terminus is essential for hTNF-α trimer conformation. Liu H, Dai L, Hao Z, Huang W, Yang Q. Biochimie; 2012 Apr 25; 94(4):1001-8. PubMed ID: 22245504 [Abstract] [Full Text] [Related]
7. Novel muteins of human tumor necrosis factor alpha. Ito R, Matsumoto H, Uchida K, Kubo T, Tsukii Y, Endo T, Kaji A. Biochim Biophys Acta; 1991 Apr 15; 1096(3):245-52. PubMed ID: 2018798 [Abstract] [Full Text] [Related]
8. [Synthesis of an artificial gene coding for thymosin alpha1 and its expression in Escherichia coli as a hybrid with human tumor necrosis factor]. Korobko VG, Boldyreva EF, Filippov SA, Berkova NP, Dobrynin VN, Shmelev VA, Popov SG, Evsegneev SI, Nosova LIu. Bioorg Khim; 1992 May 15; 18(5):646-59. PubMed ID: 1417992 [Abstract] [Full Text] [Related]
9. Extracellular production of human tumor necrosis factor-alpha by Escherichia coli using a chemically-synthesized gene. Nakamura S, Masegi T, Kitai K, Ichikawa Y, Kudo T, Aono R, Horikoshi K. Agric Biol Chem; 1990 Dec 15; 54(12):3241-50. PubMed ID: 1368641 [Abstract] [Full Text] [Related]
10. Amino acid sequence of natural tumor necrosis factor alpha inhibitor purified from human urine. Kajihara J, Asada A, Kirihara S, Kato K. Biosci Biotechnol Biochem; 1994 Dec 15; 58(12):2266-8. PubMed ID: 7765720 [Abstract] [Full Text] [Related]
11. Glycine68 to histidine73 has an important role in the function of human tumor necrosis factor alpha. Cen B, Jin W, Wu H, Lu J, Dong X, Xu X. Biochem Mol Biol Int; 1997 Sep 15; 43(1):47-52. PubMed ID: 9315281 [Abstract] [Full Text] [Related]
12. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. Cao P, Mei JJ, Diao ZY, Zhang Sq. Protein Expr Purif; 2005 May 15; 41(1):199-206. PubMed ID: 15802238 [Abstract] [Full Text] [Related]
13. Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF). Kłysik J, Konarzewska-Zglińska A, Gałazka G, Uznański B, Okruszek A, Guga P, Wilk A, Koziołkiewicz M, Tchórzewski H, Zembala M. Arch Immunol Ther Exp (Warsz); 1991 May 15; 39(4):349-55. PubMed ID: 1821611 [Abstract] [Full Text] [Related]
14. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region. Soma G, Kitahara N, Tsuji Y, Kato M, Oshima H, Gatanaga T, Inagawa H, Noguchi K, Tanabe Y, Mizuno D. Biochem Biophys Res Commun; 1987 Oct 29; 148(2):629-35. PubMed ID: 3318824 [Abstract] [Full Text] [Related]
15. [An effective method of purifying recombinant human tumor necrosis factor alpha]. Tikhonov RV, Iakimov SA, Korobko VG, Vul'fson AN. Bioorg Khim; 1996 Mar 29; 22(3):163-7. PubMed ID: 8687507 [Abstract] [Full Text] [Related]
16. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha. Yamagishi J, Kawashima H, Matsuo N, Ohue M, Yamayoshi M, Fukui T, Kotani H, Furuta R, Nakano K, Yamada M. Protein Eng; 1990 Aug 29; 3(8):713-9. PubMed ID: 2217144 [Abstract] [Full Text] [Related]
17. Optimization of BLyS production and purification from Escherichia coli. Laird MW, Sampey GC, Johnson K, Zukauskas D, Pierre J, Hong JS, Cooksey BA, Li Y, Galperina O, Karwoski JD, Burke RN. Protein Expr Purif; 2005 Feb 29; 39(2):237-46. PubMed ID: 15642475 [Abstract] [Full Text] [Related]
18. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture. Hoffmann A, Müller MQ, Gloser M, Sinz A, Rudolph R, Pfeifer S. Protein Expr Purif; 2010 Aug 29; 72(2):238-43. PubMed ID: 20363332 [Abstract] [Full Text] [Related]
19. Facile purification of Escherichia coli expressed tag-free recombinant human tumor necrosis factor alpha from supernatant. Zhang C, Liu Y, Zhao D, Li X, Yu R, Su Z. Protein Expr Purif; 2014 Mar 29; 95():195-203. PubMed ID: 24412132 [Abstract] [Full Text] [Related]